Deepmala Agarwal
Louisiana State University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Deepmala Agarwal.
Hypertension | 2012
Jeffrey P. Cardinale; Srinivas Sriramula; Nithya Mariappan; Deepmala Agarwal; Joseph Francis
Hypertension is considered a low-grade inflammatory condition, and understanding the role of transcription factors in guiding this response is pertinent. A prominent transcription factor that governs inflammatory responses and has become a focal point in hypertensive research is nuclear factor-&kgr;B (NF&kgr;B). Within the hypothalamic paraventricular nucleus (PVN), a known brain cardioregulatory center, NF&kgr;B becomes potentially even more important in ultimately coordinating the systemic hypertensive response. To definitively demonstrate the role of NF&kgr;B in the neurogenic hypertensive response, we hypothesized that PVN NF&kgr;B blockade would attenuate angiotensin II–induced hypertension. Twelve-week–old male Sprague-Dawley rats were implanted with radiotelemetry probes for blood pressure measurement and allowed a 7-day recovery. After baseline blood pressure recordings, rats were administered either continuous NF&kgr;B decoy oligodeoxynucleotide infusion or microinjection of a serine mutated adenoviral inhibitory-&kgr;B vector, or their respective controls, bilaterally into the PVN to inhibit NF&kgr;B at two levels of its activation pathway. Simultaneously, rats were implanted subcutaneously with an angiotensin II or saline-filled 14-day osmotic minipump. After the 2-week treatments, rats were euthanized and brain tissues collected for PVN analysis. Bilaterally inhibited NF&kgr;B rats had a decrease in blood pressure, NF&kgr;B p65 subunit activity, proinflammatory cytokines, and reactive oxygen species, including the angiotensin II type 1 receptor, angiotensin-converting enzyme, tumor necrosis factor, and superoxide in angiotensin II–treated rats. Moreover, after NF&kgr;B blockade, key protective antihypertensive renin-angiotensin system components were upregulated. This demonstrates the important role that transcription factor NF&kgr;B plays within the PVN in modulating and perpetuating the hypertensive response via renin-angiotensin system modulation.
Cardiovascular Research | 2014
Rahul Dange; Deepmala Agarwal; Gustavo S. Masson; Jorge Vila; Brad Wilson; Anand R. Nair; Joseph Francis
AIMS Understanding the novel signalling pathways involved in the pathogenesis of hypertension is vital for the development of effective therapeutic strategies. Recent evidence suggests a role for Toll-like receptor (TLR) 4 in the development of cardiovascular diseases. Although brain has been implicated in the pathogenesis of hypertension, the role of brain TLR4 in hypertension is largely unexplored. Therefore, we investigated the role of brain TLR4 in angiotensin (Ang) II-induced hypertension and whether central TLR4 blockade has cardioprotective effects in hypertension. METHODS AND RESULTS Hypertension was induced in male Sprague-Dawley rats by delivering AngII for 14 days. The rats were administered either specific TLR4 blocker, viral inhibitory peptide (VIPER), or control peptide, intracerebroventricularly. Blood pressure, and cardiac hypertrophy and function, was evaluated by radiotelemetry and echocardiography, respectively. Blood and paraventricular nucleus were collected for measurement of plasma norepinephrine (NE), tumour necrosis factor-alpha (TNF-α), interleukin (IL)-1β, and TLR4 expression, respectively. Heart was analysed for TNF-α, IL-1β, inducible nitric oxide synthase (iNOS), nuclear factor-kappa B (NFκB), and renin-angiotensin system (RAS) components. Hypertensive rats had dramatically increased TLR4 expression compared with normotensive rats. Central blockade of TLR4 delayed progression of hypertension and improved cardiac hypertrophy and function in hypertensive rats. TLR4 blockade significantly reduced myocardial TNF-α, IL-1β, iNOS levels, NFκB activity, and altered RAS components in hypertensive rats. These results were associated with reduced circulating NE levels in VIPER-treated hypertensive rats. CONCLUSION These results provide mechanistic evidence that AngII-induced hypertensive effects are mediated, at least in part, by brain TLR4, and that brain TLR4 blockade attenuates AngII-induced hypertensive response, possibly via down-regulation of myocardial inflammatory molecules and sympathetic activity.
Hypertension | 2009
Deepmala Agarwal; Masudul Haque; Srinivas Sriramula; Nithya Mariappan; Romain Pariaut; Joseph Francis
Hypertension is a well-known risk factor for various cardiovascular diseases. Recently, exercise has been recommended as a part of lifestyle modification for all hypertensive patients. However, the precise mechanisms of exercise training (ExT)–induced effects on the development of hypertension are poorly understood. Therefore, we hypothesized that chronic ExT would delay the progression of hypertension in young spontaneously hypertensive rats (SHRs). In addition, we explored whether the beneficial effects of chronic ExT were mediated by reduced proinflammatory cytokines and improved redox status. We also investigated the involvement of nuclear factor-&kgr;B in exercise-induced effects. To test our hypotheses, young normotensive (Wistar-Kyoto) and SHRs were given moderate-intensity ExT for 16 weeks. Blood pressure was determined by the tail-cuff method, and cardiac function was assessed by echocardiography. Myocardial total reactive oxygen species and superoxide production were measured by electron paramagnetic resonance spectroscopy; tumor necrosis factor-&agr;, interleukin-1&bgr;, gp91phox, and inducible NO synthase by real-time PCR; and nuclear factor &kgr;B activity by electrophoretic mobility shift assay. Chronic ExT in hypertensive rats resulted in significantly reduced blood pressure, reduced concentric hypertrophy, and improved diastolic function. ExT significantly reduced proinflammatory cytokines and inducible NO synthase, attenuated total reactive oxygen species and superoxide production, and increased antioxidants in SHRs. ExT also resulted in increased NO production and decreased nuclear factor &kgr;B activity in SHRs. In summary, chronic ExT delays the progression of hypertension and improves cardiac function in young SHRs; these ExT-induced beneficial effects are mediated by reduced proinflammatory cytokines and improved redox homeostasis via downregulation of nuclear factor-&kgr;B.
Antioxidants & Redox Signaling | 2012
Deepmala Agarwal; Carrie M. Elks; Scott D. Reed; Nithya Mariappan; Dewan S.A. Majid; Joseph Francis
AIMS Exercise training (ExT) is a recommended adjunct to many pharmaceutical antihypertensive therapies. The effects of chronic ExT on the development of hypertension-induced renal injury remain unknown. We examined whether ExT would preserve renal hemodynamics and structure in the spontaneously hypertensive rat (SHR), and whether these effects were mediated by improved redox status and decreased inflammation. Normotensive WKY rats and SHR underwent moderate-intensity ExT for 16 weeks. One group of SHR animals was treated with hydralazine to investigate the pressure-dependent/independent effects of ExT. Acute renal clearance experiments were performed prior to sacrifice. Tissue free radical production rates were measured by electron paramagnetic resonance; gene and protein expression were measured by real time RT-PCR and Western blot or immunofluorescence, respectively. Plasma angiotensin II levels and kidney antioxidants were assessed. Training efficacy was assessed by citrate synthase activity assay in hind-limb muscle. RESULTS ExT delayed hypertension, prevented oxidative stress and inflammation, preserved antioxidant status, prevented an increase in circulating AngII levels, and preserved renal hemodynamics and structure in SHR. In addition, exercise-induced effects, at least, in part, were found to be pressure-independent. INNOVATION This study is the first to provide mechanistic evidence for the renoprotective benefits of ExT in a model of hypertension. Our results demonstrate that initiation of ExT in susceptible patients can delay the development of hypertension and provide renoprotection at the functional and ultrastructural level. CONCLUSION Chronic ExT preserves renal hemodynamics and structure in SHR; these effects are partially mediated by improved redox status and decreased inflammation.
British Journal of Pharmacology | 2013
Deepmala Agarwal; Rahul Dange; Mohan K. Raizada; Joseph Francis
Emerging evidence indicates that the balance between pro‐inflammatory cytokines (PICs) and anti‐inflammatory cytokines (AICs) within the brain is an important determinant in the outcome of hypertension. However, the mechanism by which this dysregulation occurs is not known. We aimed to investigate whether AngII induces imbalance between PIC and AIC by modulating downstream transcription factors, NFκB and cyclic AMP response element‐binding protein (CREB), and whether AngII‐induced effects are mediated by glycogen synthase kinase‐3β (GSK‐3β).
PLOS ONE | 2012
Deepmala Agarwal; Rahul Dange; Jorge Vila; Arturo J. Otamendi; Joseph Francis
Aims This study sought to investigate the effects of physical detraining on blood pressure (BP) and cardiac morphology and function in hypertension, and on pro- and anti-inflammatory cytokines (PICs and AIC) and oxidative stress within the brain of hypertensive rats. Methods and Results Hypertension was induced in male Sprague-Dawley rats by delivering AngiotensinII for 42 days using implanted osmotic minipumps. Rats were randomized into sedentary, trained, and detrained groups. Trained rats underwent moderate-intensity exercise (ExT) for 42 days, whereas, detrained groups underwent 28 days of exercise followed by 14 days of detraining. BP and cardiac function were evaluated by radio-telemetry and echocardiography, respectively. At the end, the paraventricular nucleus (PVN) was analyzed by Real-time RT-PCR and Western blot. ExT in AngII-infused rats caused delayed progression of hypertension, reduced cardiac hypertrophy, and improved diastolic function. These results were associated with significantly reduced PICs, increased AIC (interleukin (IL)-10), and attenuated oxidative stress in the PVN. Detraining did not abolish the exercise-induced attenuation in MAP in hypertensive rats; however, detraining failed to completely preserve exercise-mediated improvement in cardiac hypertrophy and function. Additionally, detraining did not reverse exercise-induced improvement in PICs in the PVN of hypertensive rats; however, the improvements in IL-10 were abolished. Conclusion These results indicate that although 2 weeks of detraining is not long enough to completely abolish the beneficial effects of regular exercise, continuing cessation of exercise may lead to detrimental effects.
Basic Research in Cardiology | 2011
Deepmala Agarwal; Michael A. Welsch; Jeffrey N. Keller; Joseph Francis
American Journal of Respiratory and Critical Care Medicine | 2013
Vinayak Shenoy; Altin Gjymishka; Yagna P. R. Jarajapu; Yanfei Qi; Aqeela Afzal; Katya Rigatto; Anderson J. Ferreira; R. A. Fraga-Silva; Patrick N. Kearns; Jane Yellowlees Douglas; Deepmala Agarwal; Kamal K. Mubarak; Chastity N. Bradford; William R. Kennedy; Joo Yun Jun; Anandharajan Rathinasabapathy; Erin Bruce; Dipankar Gupta; Arturo J. Cardounel; J Mocco; Jawaharlal M. Patel; Joseph Francis; Maria B. Grant; Michael J. Katovich; Mohan K. Raizada
Archive | 2015
Bradley M. Palmer; Joshua M. Lynch; Russell L. Moore; Zengyi Chen; Richard R. Lachapelle; Edith D. Hendley; M Martin; Julien Boissiere; Véronique Eder; Marie-Christine Machet; Daniel Courteix; Pierre Bonnet; Joseph Francis; Deepmala Agarwal; Masudul Haque; Srinivas Sriramula; Nithya Mariappan; Romain Pariaut
Archive | 2015
Pierre Bonnet; Julien Boissiere; Véronique Eder; Marie-Christine Machet; Daniel Courteix; Joseph Francis; Rahul Dange; Deepmala Agarwal; Gustavo S. Masson; Jorge Vila; Brad Wilson; Anand R. Nair